10.3945/ajcn.113.068437 20 ChoungY
These include semaglutide (Wegovy) and liraglutide (Saxenda), along with newer combination agents like tirzepatide (Zepbound), which targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors
Why Semaglutide Compounding Gives You Dosing Flexibility Compounded semaglutide from licensed 503A pharmacies allows finer dose adjustments than branded Wegovy pens, which come in fixed increments (0.25, 0.5, 1.0, 1.7, and 2.4 mg)
The most common side effects are gastrointestinal in nature nausea, diarrhea, vomiting, and constipation
Endorsement by Medical Community and Advocacy Groups : Acceptance by healthcare professionals specializing in PWS and support from patient advocacy groups would enhance the potential for CT-PYY to be integrated into standard care